Literature DB >> 25172501

Macrophage migration inhibitory factor triggers chemotaxis of CD74+CXCR2+ NKT cells in chemically induced IFN-γ-mediated skin inflammation.

Chia-Yuan Hsieh1, Chia-Ling Chen2, Yee-Shin Lin3, Trai-Ming Yeh4, Tsung-Ting Tsai5, Ming-Yuan Hong1, Chiou-Feng Lin6.   

Abstract

IFN-γ mediates chemically induced skin inflammation; however, the mechanism by which IFN-γ-producing cells are recruited to the sites of inflammation remains undefined. Secretion of macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, from damaged cells may promote immune cell recruitment. We hypothesized that MIF triggers an initial step in the chemotaxis of IFN-γ-producing cells in chemically induced skin inflammation. Using acute and chronic models of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in mouse ears, MIF expression was examined, and its role in this process was investigated pharmacologically. The cell populations targeted by MIF, their receptor expression patterns, and the effects of MIF on cell migration were examined. TPA directly caused cytotoxicity accompanied by MIF release in mouse ear epidermal keratinocytes, as well as in human keratinocytic HaCaT cells. Treatment with the MIF antagonist (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester considerably attenuated TPA-induced ear swelling, leukocyte infiltration, epidermal cell proliferation, and dermal angiogenesis. Inhibition of MIF greatly diminished the dermal infiltration of IFN-γ(+) NKT cells, whereas the addition of exogenous TPA and MIF to NKT cells promoted their IFN-γ production and migration, respectively. MIF specifically triggered the chemotaxis of NKT cells via CD74 and CXCR2, and the resulting depletion of NKT cells abolished TPA-induced skin inflammation. In TPA-induced skin inflammation, MIF is released from damaged keratinocytes and then triggers the chemotaxis of CD74(+)CXCR2(+) NKT cells for IFN-γ production.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172501     DOI: 10.4049/jimmunol.1400692

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.

Authors:  Bong-Sung Kim; Norbert Pallua; Jürgen Bernhagen; Richard Bucala
Journal:  Exp Mol Med       Date:  2015-05-01       Impact factor: 8.718

Review 2.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

Review 3.  Deep Insight into the Role of MIF in Spondyloarthritis.

Authors:  Brian Wu; Akihiro Nakamura
Journal:  Curr Rheumatol Rep       Date:  2022-07-09       Impact factor: 4.686

Review 4.  The biological function and significance of CD74 in immune diseases.

Authors:  Huiting Su; Ning Na; Xiaodong Zhang; Yong Zhao
Journal:  Inflamm Res       Date:  2016-10-17       Impact factor: 4.575

5.  MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.

Authors:  Juan de Dios Ruiz-Rosado; Jonadab E Olguín; Imelda Juárez-Avelar; Rafael Saavedra; Luis I Terrazas; Frank H Robledo-Avila; Alicia Vazquez-Mendoza; Jacquelina Fernández; Abhay R Satoskar; Santiago Partida-Sánchez; Miriam Rodriguez-Sosa
Journal:  Mediators Inflamm       Date:  2016-02-29       Impact factor: 4.711

6.  Spinal Cord T-Cell Infiltration in the Rat Spared Nerve Injury Model: A Time Course Study.

Authors:  Christophe Gattlen; Christine B Clarke; Nicolas Piller; Guylène Kirschmann; Marie Pertin; Isabelle Decosterd; Romain-Daniel Gosselin; Marc R Suter
Journal:  Int J Mol Sci       Date:  2016-03-09       Impact factor: 5.923

7.  Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.

Authors:  Abhay Kumar Singh; Georgios Pantouris; Sebastian Borosch; Siripong Rojanasthien; Thomas Yoonsang Cho
Journal:  J Cell Mol Med       Date:  2016-09-13       Impact factor: 5.310

8.  Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.

Authors:  Michael Lacy; Christos Kontos; Markus Brandhofer; Kathleen Hille; Sabine Gröning; Dzmitry Sinitski; Priscila Bourilhon; Eric Rosenberg; Christine Krammer; Tharshika Thavayogarajah; Georgios Pantouris; Maria Bakou; Christian Weber; Elias Lolis; Jürgen Bernhagen; Aphrodite Kapurniotu
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

9.  Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland.

Authors:  Yao Mawulikplimi Adzavon; Pengxiang Zhao; Jianmin Ma; Xujuan Zhang; Xin Zhang; Mingzi Zhang; Mengyu Liu; Limin Wang; Danying Chen; Tarekegn Gebreyesus Abisso; Baobei Lv; Lei Wang; Fei Xie; Xuemei Ma
Journal:  Cell Commun Signal       Date:  2018-10-22       Impact factor: 5.712

10.  T and B Lymphocyte Transcriptional States Differentiate between Sensitized and Unsensitized Individuals in Alpha-Gal Syndrome.

Authors:  Onyinye I Iweala; Shailesh K Choudhary; Claire T Addison; Scott P Commins
Journal:  Int J Mol Sci       Date:  2021-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.